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The Drosophila dysfusion basic-helix-loop-helix–PAS transcription factor gene is expressed in specialized
fusion cells that reside at the tips of migrating tracheal branches. dysfusion mutants were isolated, and genetic
analysis of live embryos revealed that mutant tracheal branches migrate to close proximity but fail to recognize
and adhere to each other. Misexpression of dysfusion throughout the trachea further indicated that dysfusion
has the ability to both inhibit cell migration and promote ectopic tracheal fusion. Nineteen genes whose
expression either increases or decreases in fusion cells during development were analyzed in dysfusion mutant
embryos. dysfusion upregulates the levels of four genes, including the shotgun cell adhesion protein gene and the
zona pellucida family transmembrane protein gene, CG13196. Misexpression experiments with CG13196 result
in ectopic tracheal fusion events, suggesting that it also encodes a cell adhesion protein. Another target gene
of dysfusion is members only, which inhibits protein nuclear export and influences tracheal fusion. dysfusion also
indirectly downregulates protein levels of Trachealess, an important regulator of tracheal development. These
results indicate that fusion cells undergo dynamic changes in gene expression as they switch from migratory
to fusion modes and that dysfusion regulates a discrete, but important, set of these genes.
One important aspect of insect tracheal morphogenesis in-
volves the fusion of tracheal branches to form an intercon-
nected oxygen-bearing tubular network (8). Branches contain a
specialized fusion cell at their tips (26). These fusion cells
extend actin-rich filopodia (24, 31) that guide migration in
response to guidance cues, similar to axonal growth cone guid-
ance (6). Thus, tracheal branches from adjacent hemiseg-
ments are directed to close proximity by the external guid-
ance cues and then recognize and adhere to each other.
After joining, further cellular changes occur, including (i)
cytoskeletal reorganization, (ii) the breaking and reassem-
bling of cellular junctions, and (iii) the formation of a con-
tinuous lumen (34). The complexity of tracheal branching
and fusion suggests that the fusion cell is a complex, dy-
namic structure with changing patterns of gene expression.
One of the major challenges in studying tracheal morpho-
genesis is to understand how regulatory pathways control
and coordinate these changes in gene expression.
The molecular biology, cell biology, and genetics of branch
migration and fusion have been productively studied in recent
years. The trachea-expressed Breathless (Btl) tyrosine kinase
receptor is activated by Branchless and is required for filopo-
dial extension and migration (14, 24, 30). Additional proteins,
such as Roundabout (Robo), Robo2, and Slit, are involved in
branch-specific pathfinding (6). Analysis of enhancer trap lines
first led to the identification of genes prominently expressed in
or absent from fusion cells (26), and their regulation was ini-
tiated with the discovery of the escargot (esg) gene (27, 31),
which encodes a zinc finger transcription factor. esg is ex-
pressed specifically in fusion cells during branching, and esg
mutants have defects in tracheal fusion. Several genes whose
expression is dependent on esg were identified. They included
shotgun (shg), whose levels are upregulated in fusion cells, and
Drosophila serum response factor (DSRF), which is expressed in
adjacent terminal tracheal cells but repressed in fusion cells.
Shg, a cadherin cell surface protein, is implicated in adhesive
interactions and the formation of new adherens junctions in
the fused trachea (31, 33). These results and other discoveries
began to dissect the cellular and molecular bases of tracheal
branch migration and fusion.
Another transcriptional target of Esg is dysfusion (dys),
which encodes a basic-helix-loop-helix–PAS (bHLH-PAS)
transcription factor that is expressed specifically in all fusion
cells (12). RNA interference (RNAi)-mediated reduction of
Drosophila dys function demonstrated that the dorsal branches
(DBs), lateral trunk (LT) branches, and ganglionic branches
(GBs) failed to fuse, although the cellular and molecular na-
tures of these defects were not assessed. Dys is evolutionarily
well conserved with a human ortholog (NXF or LE-PAS) that
is prominently expressed in the brain (17, 21) and with a
Caenorhabditis elegans ortholog (C15C8.2) that is expressed in
the pharynx (23). Particularly noteworthy is the existence of
several other Drosophila bHLH-PAS proteins that have impor-
tant roles in tracheal development. The trachealess (trh) gene
plays an early role in initiating tracheagenesis (10, 37) and
directly regulates btl (20). The similar (sima) gene encodes the
Drosophila ortholog of mammalian hypoxia-inducible factors
(19) and functions in trachea to control the transcriptional
response to hypoxia (1, 4, 16). All three proteins function as
heterodimers with the same bHLH-PAS protein, Tango (Tgo)
(29). Interestingly, Trh levels in fusion cells are reduced as Dys
appears, and the reduction is dependent on dys function (12).
Several questions arise regarding the function of dys. At the
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cellular level, does Dys function in branch migration, cell rec-
ognition/adhesion, or fusion events? What genes are regulated
by dys, and do they constitute a functionally discrete subset of
esg-regulated genes? Do dys-regulated genes share common
biochemical functions? Are Trh protein levels and other genes
downregulated by dys via transcriptional, posttranscriptional,
or competitive mechanisms? How widespread are transcrip-
tional changes in fusion cells?
In this study, the dynamics of fusion cell gene expression
were examined and the functional role of dys investigated in
much greater detail than previously reported. dys mutants were
isolated, and analysis of their phenotypes showed that branch
migration is normal but fusion cells fail to stably adhere, re-
sulting in a failure of tracheal fusion. Misexpression of dys
throughout the trachea resulted in severely malformed trachea
in which secondary and tertiary branching was stunted and
lumen formation inhibited at fusion sites. In addition, misex-
pression embryos often showed ectopic fusion events. Nine-
teen trachea-expressed genes were analyzed in wild-type and
dys mutant embryos. Levels of four fusion cell-expressed genes
declined in dys mutants. Misexpression of dys also resulted in
ectopic expression of target genes. Two target genes are im-
plicated in tracheal cell adhesion: shg and CG13196, a zona
pellucida (ZP) gene (11). Embryos that misexpress CG13196
showed tracheal abnormalities consistent with it functioning as
an adhesion protein gene. In addition, dys can indirectly reg-
ulate fusion cell protein levels and subcellular localization.
Thus, dys controls multiple aspects of tracheal fusion, by up-
regulating and downregulating fusion cell constituents by using
direct and indirect biochemical mechanisms.
MATERIALS AND METHODS
Drosophila strains. The Drosophila strain Df(3R)Espl3 [96F1; 97B1] is deleted
for the dys gene and was utilized in an ethyl methanesulfonate (EMS) screen to
obtain dys mutants. Additional deletion strains used to characterize the EMS-
generated mutants were Df(3R)Exel6204 [96F9; 97A6] and Df(3R)ME61 [96F12-
14; 97C4-5] (all three deficiency strains are available from the Bloomington
Drosophila Stock Center). In addition, the EMS-generated mutants were crossed
to gro1, which is uncovered by Df(3R)Espl3. Misexpression experiments utilized
btl-Gal4 (Tien Hsu) (28), engrailed (en)-Gal4 (Mark Peifer) (36), and UAS-green
fluorescent protein (GFP) transgenic strains. UAS-actin-GFP (Mark Peifer) was
used in the live imaging experiments. The following trachea-expressed lacZ
enhancer trap and transgenic lines were crossed into a dys2 mutant background:
Fusion-4 (members only [mbo]), Fusion-5 (bloated tubules [blot]), Antifusion-1
(CrebA), and Terminal-3 (ribbon) (all from Mark Krasnow) and shg-lacZ (Shigeo
Hayashi) (26, 31). All dys mutant strains were balanced over P[w; Kr-Gal4
UAS-GFP] (3) so that homozygous mutant embryos could be unambiguously
identified.
Isolation of EMS-generated dys mutants. Mutations in dys were identified in a
two-step procedure in which EMS mutations were screened over Df(3R)Espl3 for
lethality and then examined for tracheal fusion defects. Isogenic w; es males were
starved overnight and then fed a 1% sucrose solution with 25 mM EMS (Sigma)
for 12 h. The mutagenized (*) males were then mated en masse to w; D/TM3
females. Male progeny (10,000) of the genotype w; es */TM3 were individually
crossed to Df(3R)Espl3/TM3 e P[w; Kr-Gal4 UAS-GFP] females. Males were
discarded, and lack of complementation to Df(3R)Espl3 was assayed by scoring
the vials for the absence of Sb flies. Mutant stocks (es */TM3 e P[w; Kr-Gal4
UAS-GFP]) were generated from 53 vials with no Sb flies. Stocks were crossed
inter se for complementation and representatives of each complementation
group crossed to Df(3R)Exel6204 and Df(3R)ME61 for further genetic mapping.
Members of each complementation group were assayed for tracheal fusion
defects resembling the dys RNAi fusion defect (12).
Phenotypic analysis of larvae. Second-instar larvae homozygously mutant for
dys were placed onto grape juice agar plates and chilled at 4°C for 30 min. The
larvae were then transferred to a slide and covered in 70% glycerol, and their
trachea were examined by bright-field microscopy.
DNA sequence analysis of dys mutants. Sequence analysis of the dys gene in
dys mutant strains was carried out on genomic DNA isolated from homozygous
dys EMS mutant embryos. The mutant embryos, balanced over P[w; Kr-Gal4
UAS-GFP], were examined under a GFP stereoscope and selected manually by
their absence of GFP fluorescence. The genomic DNA used as a template for
PCRs encompassed the coding sequence and splice sites for all 10 dys exons.
Immunostaining and in situ hybridization of embryos. Whole-mount embryos
were immunostained and hybridized by in situ hybridization using standard
techniques (13, 22). The following primary antibodies were used for immuno-
staining: anti-DSRF mouse monoclonal antibody (MAb) (Active Motif), rat
anti-Dys, rabbit anti-Dys, MAb 2A12, rabbit anti-diphospho-extracellular signal-
regulated kinase (Sigma E7028), anti-Tgo MAb, anti--galactosidase MAb, rab-
bit anti--galactosidase, and rat anti-Trh. The following secondary antibodies
were used: Alexafluor 546-labeled anti-mouse immunoglobulin M (IgM), Alex-
afluor 488-labeled anti-rat IgG, and Cy5-labeled anti-rabbit IgG. Plasmids con-
taining apontic (apt), btl, center divider (cdi), CG13196, CG15252, dys, esg, head-
case (hdc), knirps (kni), knirps-related (knrl), trh, and ventral veinless (vvl) cDNA
clones (all from Origene except dys) were used to generate RNA probes for in
situ hybridization. Embryos were examined using a Zeiss 510 confocal micro-
scope.
Generation of UAS-dys transgenes. UAS-dys and UAS-b-dys transgenes were
generated for misexpression experiments. A cDNA fragment containing a copy
of the dys coding region was cloned into the EcoRI site of pUAST (2) to create
UAS-dys. The UAS-b-dys transgene contained a copy of the dys coding sequence
with a deletion of the entire Dys basic region (ANKSTKGASKMRR) cloned
into the XbaI site of pUAST. Two UAS-dys lines were analyzed and showed
similar tracheal defects. Seven UAS-dys-b lines were analyzed; all had the same
wild-type tracheal morphology upon misexpression.
Time-lapse observations of tracheal branch migration and fusion. Imaging of
tracheal migration and fusion was carried out by examining wild-type and dys
mutant P[btl-Gal4] P[UAS-actin-GFP] embryos, in which actin-GFP was ex-
pressed in the trachea (24). The dys mutant chromosome was balanced over TM3
P[Kr-Gal4] P[UAS-GFP]. Homozygous dys mutants were identified because of
cortical actin-GFP in the trachea, due to UAS-actin-GFP expression, whereas
nonmutant embryos with one or two copies of TM3 P[Kr-Gal4] P[UAS-GFP]
showed cytoplasmic GFP in the trachea, due to the presence of cytoplasmic GFP
driven by btl-Gal4 acting on P[UAS-GFP]. Embryos were collected at room
temperature and dechorionated. They were then mounted on a glass coverslip
and immersed in halocarbon oil 700 (Sigma) on slides containing an oxygen-
permeable membrane. GFP fluorescent images were captured on a Zeiss LSM-
510 confocal microscope with a 60 oil immersion lens for 2 h (wild-type
embryos) and 4 h (dys mutant embryos). Typically, projections consisted of ten
2-m slices captured along the z axis every 2 min for wild-type embryos and every
4 min for dys mutant embryos. Movies were assembled from projections by using
Image J software.
RESULTS
Isolation of dys mutant alleles. The strategy for isolating dys
mutants was based on RNAi results. Previously, it was shown
that injection of dys double-stranded RNA into Drosophila
embryos resulted in (i) a loss of detectable Dys protein, (ii)
embryonic and larval tracheal fusion defects, and (iii) a high
degree of larval lethality (12). These results provided the basis
for an EMS screen for dys mutants (Fig. 1), based on dys being
a vital locus with easily detectable tracheal defects. In our
screen, mutagenized males were crossed to a deletion strain,
Df(3R)Espl3, that removes dys, and stocks that failed to com-
plement the deficiency strain were screened for tracheal de-
fects. Representative mutant larvae from each complementa-
tion group were analyzed for tracheal defects by examination
with phase-contrast microscopy. Mutant larvae from group 3
(Table 1), which contains nine different mutants, had tracheal
fusion defects (Fig. 2A to F) identical to those observed in the
dys RNAi embryos (12). Identical, severe tracheal fusion phe-
notypes were observed in homozygous mutants of all nine dys
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alleles, when examined as either second-instar larvae or stage
17 embryos. Embryos heterozygous for combinations of two
different dys alleles and dys/Df(3R)Espl3 mutants all showed
similar severe phenotypes identical to those of homozygous dys
mutants. Thus, all mutants appear to have a severe, genetically
null dys phenotype. dys mutant strains are lethal, with animals
dying as second- or third-instar larvae.
DNA sequence analysis of dys exons and intron/exon bound-
aries derived from homozygous mutant embryo genomic DNA
was used to confirm that complementation group 3 mutants
corresponded to the dys gene. The results are summarized in
Fig. 3. Three alleles have premature stop codons: dys2 and dys3
have termination codons in the HLH region, and dys7 has a
termination codon in the PAS-2 domain. Three alleles, dys4,
dys5, and dys6, have mutations that likely affect splicing and
would result in proteins truncated within or at the end of the
PAS-2 domain. The remaining three alleles show no obvious
mutation in the coding region or splice sites. All six dys alleles
with recognizable mutations are predicted to produce trun-
cated proteins that lack the C-terminal region, which was used
as an antigen to generate Dys antibody (Fig. 3). Consistent
with the sequencing data, no Dys immunoreactivity was de-
tected in homozygous mutant embryos from any of these
strains (data not shown). Wild-type levels of dys RNA were
present in the two dys mutants assayed, dys2 and dys3, suggest-
ing that dys expression is not maintained in tracheal cells by
positive autoregulation (data not shown).
dys mutants show tracheal adhesion and fusion defects. dys
mutants were initially examined for larval defects in tracheal
fusion (Fig. 2A to F). The GBs, DBs, and LT branches in dys
mutant embryos showed a complete absence of fusion in all
branches examined. The dorsal trunk (DT) (Fig. 2B) was fused
and relatively normal in appearance, although some DT fusion
sites were constricted (Fig. 2D). These results were identical to
those observed with the dys RNAi experiments (12). Pen-
etrance and expressivity were 100% for dys2/dys3 mutant lar-
vae, as well as for other dys alleles and allelic combinations
analyzed. In each case, the mutant tracheal branches had mi-
grated near the point of fusion but failed to fuse. These results
were confirmed by staining stage 16 embryos with MAb 2A12,
which stains the tracheal lumen (Fig. 2G and H). Mutant
embryos showed an absence of fusion by stage 16.
More-detailed analyses of dys mutant embryos were carried
out by employing time-lapse microscopy of tracheal migration
and fusion (Fig. 4 and data not shown). Wild-type and dys
mutant embryos containing btl-Gal4 UAS-actin-GFP were vi-
sualized for GFP fluorescence by using confocal microscopy
and compared over 4 h of development with respect to migra-
tion, filopodial dynamics, and fusion. The btl-Gal4 transgene
expresses Gal4 in most tracheal cells, and UAS-actin-GFP al-
lows visualization of actin-rich structures, including tracheal
filopodia (24). We focused on the DB, which migrates over
large distances along the internal surface of the dorsal epider-
mis to meet and fuse at the dorsal midline with its partner from
the adjacent hemisegment. In both wild-type and dys mutant
embryos, the migratory processes, including filopodial exten-
sion, were similar. However, in wild-type embryos, the filopo-
dia from the fusion cells touched and adhered, and the fusion
cells joined together (Fig. 4A to E). The fusion event was
accompanied by intense actin accumulation at the fusion junc-
tion. In mutant embryos (Fig. 4F to N), the two fusion cells
migrated close to each other, and filopodia made contact.
However, the cells failed to adhere and remained separated. In
summary, the time-lapse movies indicated that long-range mi-
gration in dys mutant embryos is sufficiently normal that fusion
cells contact each other via their filopodia. However, the
branches fail to stably adhere and fuse.
Misexpression of dys results in ectopic fusion and inhibition
of tracheal migration and lumen formation. Additional insight
into the function of dys was obtained by misexpressing the gene
in trachea by using UAS-dys transgenic fly strains crossed to
btl-Gal4. This results in dys being expressed at high levels in
most tracheal cells (Fig. 5A). Staining of w control embryos
with MAb 2A12 revealed the characteristic and extensive sec-
ondary and tertiary branches and branch fusion (Fig. 5B).
However, MAb 2A12 staining and examination of GFP in
btl-Gal4 UAS-dys UAS-GFP embryos indicated a striking re-
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a Fifty-three mutants failed to complement Df(3R)Espl3 96F1; 97B1. These
mutants were crossed inter se and placed into 15 complementation groups
numbered 1 to 15. Ten of those complementation groups also failed to comple-
ment Df(3R)Exel6204 96F9; 97A6, and five lie outside that chromosomal in-
terval. The group 3 mutants were named dys to dys in ascending order. Comple-
mentation group 2 contains alleles of groucho (gro).
FIG. 1. Isolation of EMS-mutagenized dys alleles.
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duction in DB, DT, GB, and visceral branch branching (Fig. 5C
and D). While both DT and LT branches were sometimes
fused, the connections were abnormal and were characterized
by reduced GFP-positive cytoplasmic material and an absence
of MAb 2A12 luminal staining. The dys misexpression embryos
also resulted in the formation of ectopic tracheal fusion events,
connecting tracheal branches that normally never join (Fig. 5E
and F). These ectopic fusion events rarely showed the presence
of MAb 2A12 luminal staining at the fusion sites. The dys
misexpression experiments provided evidence that dys can pro-
mote tracheal fusion events, consistent with the dys mutant
studies. However, the misexpression experiments also provided
evidence that tracheal migration can be inhibited by dys.
The biochemical mechanism of the dys misexpression phe-
notypes (and thus likely to be relevant to the dys mutant phe-
notypes) was assessed using a mutant version of dys that lacks
the putative DNA binding basic region (b-dys) in the dys
misexpression assay. Embryos that were btl-Gal4 UAS-b-dys
showed trachea that were wild type in appearance (Fig. 5G and
H). The b-dys gene was misexpressed at high levels as re-
vealed by anti-Dys immunostaining of misexpression embryos
(Fig. 5H), and it was able to dimerize with Tgo and translocate
to the nucleus as revealed by staining en-Gal4 UAS-b-dys
embryos with anti-Tgo (data not shown). Thus, the inability of
b-dys to generate misexpression phenotypes is likely due to its
inability to bind DNA. While the relationship between the dys
misexpression and mutant phenotypes is uncertain, these re-
sults indicated that the ability of dys to inhibit cell migration
and promote tracheal fusion requires the ability to bind DNA.
Regulation of fusion cell gene expression by Dys. Since Dys
is a transcription factor expressed in tracheal fusion cells, im-
portant insight into its biological function can be revealed by
identifying transcriptional target genes. We examined 19 tra-
chea-expressed genes in both wild-type and dys mutant em-
bryos for potential regulation by dys. The genes fall into three
categories: (i) those prominently expressed in fusion cells, (ii)
those expressed in terminal cells but not fusion cells, and (iii)
those expressed in tracheal cells but downregulated in fusion
cells.
(i) Fusion cell-expressed genes. Previous work identified a
number of fusion cell-expressed genes that are regulated by
esg (27), including blot, dys, hdc, mbo, and shg. Another
trachea-expressed gene, cdi, is not regulated by esg. Expres-
sion of these genes, and also esg, CG13196 (a ZP family gene
expressed in fusion cells) (11), and CG15252 (which encodes a
protein of unknown function) (32), was examined in dys mu-
tant embryos. Four genes, i.e., shg, CG13196, CG15252, and
mbo (Fig. 6A to E) were found to be regulated by dys, whereas
the other five, i.e., blot, cdi, dys, esg, and hdc, were not regu-
lated by dys (data not shown). The expression of shg is upregu-
lated by dys from a basal level, whereas dys is required for the
initiation of CG13196, CG15252, and mbo expression. shg ex-
pression is enhanced in both DB and DT fusion cells, but dys
FIG. 2. dys mutant embryos show tracheal fusion defects. Anterior
is to the left in all panels. (A to F) Trachea from wild-type and dys2/dys3
mutant second-instar larvae were examined by phase microscopy. (A
and B) Sagittal view. (A) The LT is fused (*) in a wild-type larva. The
DT, GB, and lateral branch G (LG) are shown. (B) A dys mutant larva
shows an absence of LT fusion (*). The GB and LG branch still persist
and project ventrally. The DT is fused. (C and D) Dorsal view.
(C) Wild-type larva showing fusion (*) of the DBs. (D) dys mutant
larva showing a lack of DB fusion (*), although branches (arrowheads)
are close together. Constrictions are seen in dys mutant DTs at fusion
sites (open arrowheads). (E and F) Ventral view. (E) Wild-type larva
showing fusion (*) of GBs. (F) dys mutant larva showing a lack of GB
fusion (*). (G and H) Sagittal view. Confocal microscopic analysis of
whole-mount embryos. (G) Stage 16 wild-type embryo stained with
MAb 2A12 (red) and anti-Dys (green), showing fusion (arrowheads) of
DBs, DTs, and LTs. Mab2A12 stains the tracheal lumen, and anti-Dys
stains the tracheal fusion cells. (H) Stage 16 dys mutant embryo stained
with MAb 2A12 (red) and anti-Dys (green), showing an absence of
fusion of DB and LT branches. The DT is fused. Note the absence of
anti-Dys reactivity.
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(as well as esg [31]) controls expression in only DBs and not DTs.
shg and CG13196 are membrane proteins that may control fusion
cell recognition and adhesion events, whereas mbo attenuates
protein nuclear export. Levels of shg and mbo were assayed by
examining shg-lacZ and mbo/Fusion-4-lacZ lines, indicating that
the control by dys is likely to be at the transcriptional level.
The shg gene encodes a cadherin cell adhesion protein im-
plicated in tracheal morphogenesis and branch fusion (31, 33).
CG13196 encodes a ZP protein of unknown function. An at-
tempt to abolish CG13196 function by using RNAi showed
only weak effects on tracheal fusion (data not shown). In con-
trast, misexpression of CG13196 in btl-Gal4 UAS-CG13196
embryos revealed sites of ectopic fusion (Fig. 6F), suggesting
that CG13196 encodes an adhesion protein. This suggests that
Dys controls expression of a group of two or more proteins
involved in tracheal recognition/adhesion events.
(ii) Terminal cell-expressed genes. While screening for
genes expressed in tracheal cells, Samakovlis et al. (26) iden-
tified a class of trachea-expressed genes that were expressed in
terminal cells, which in the case of DBs are adjacent to fusion
cells. Analysis of two terminal-class genes, including DSRF, in
esg mutants indicated that esg represses expression of both
genes in fusion cells. We investigated whether terminal genes,
including DSRF and ribbon, were negatively regulated by dys in
fusion cells. In both cases, expression was unaffected in fusion
cells (data not shown). While this analysis is limited to these
two genes, it indicates that the negative regulation of DSRF in
fusion cells by esg is not mediated by dys, and transcriptional
repression in fusion cells may not be a common role of dys.
(iii) Fusion cell-downregulated genes. We examined expres-
sion of a number of genes that are broadly expressed during
tracheal development and found that downregulation in fusion
cells is common. These genes included six that encode tran-
scription factors: apt, crebA (Antifusion-1), kni, knrl, trh, and vvl
(Fig. 6G to J). In addition, expression of the btl receptor, which
is a direct transcriptional target of Trh, was downregulated
(Fig. 6K). Consistent with a reduction in btl, mitogen-activated
protein kinase (MAPK) activation, as assayed by immunostain-
ing for phosphorylation with anti-diphospho-MAPK, was also
reduced (data not shown), as noted previously (9). When
FIG. 3. Molecular defects of dys mutants. At the top is a schematic of the Dys protein. The basic-region DNA binding domain (b), HLH
dimerization domain, and PAS-1 and PAS-2 domains are labeled below the schematic. Above the schematic are the amino acid positions of domain
boundaries. The locations of splice sites are shown below the domain names, and each exon-intron boundary is indicated by a vertical line with
the corresponding exon indicated on each side, along with the amino acid residue corresponding to the splice site below. The anti-Dys antibody
was raised against animals injected with a bacterial fusion protein antigen containing Dys protein residues 615 to 834. The conceptual protein
fragment predicted for each dys mutant gene is indicated by a green bar, followed by the size in amino acids. The minimum extent of the predicted
protein is shown in green, and the orange bar indicates translated intronic sequences. dys2, dys3, and dys7 have premature termination codons that
should result in a truncated protein. dys4, dys5, and dys6 have splice site mutations. dys4 and dys5 are followed by two numbers; the first indicates
the end of the exonic sequence and the second the location of the in-frame termination codon in the adjacent intron. The sequence alteration for
each mutant is shown at the bottom. Vertical lines for dys4, dys5, and dys6 indicate locations of splice sites.
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tested in dys mutants, transcript levels of all eight genes plus
the diphospho-MAPK gene remain reduced, indicating that
the downregulation is not dys dependent (data not shown).
It was noted previously that in wild-type embryos Trh pro-
tein levels were reduced in fusion cells (Fig. 6L1 and M1), and
injection of dys RNAi restored Trh protein levels to the levels
found in the adjacent tracheal cells (12). Using dys mutant and
misexpression embryos, Trh protein levels were examined in
fusion cells. In dys mutant embryos, Trh proteins levels were
comparable to the levels observed in adjacent cells in DTs (Fig.
6L2) and DBs (Fig. 6M2). Misexpression of dys in btl-Gal4
UAS-dys embryos also showed a reduction in Trh protein levels
(Fig. 6N1 to 3). In contrast, trh RNA levels were not affected
in either dys mutant or misexpression embryos (data not
shown). Misexpression of b-dys did not result in a reduction
of Trh protein levels (Fig. 6N4), indicating that Trh protein
reduction requires Dys DNA binding and transcriptional reg-
ulation. Since Trh protein levels, but not RNA levels, are
negatively regulated by Dys transcriptional activity, most likely
Dys activates transcription of an unknown gene, whose func-
tion is to regulate Trh protein levels.
Misexpression of dys results in ectopic expression of Dys
target genes. CG13196 is expressed in all tracheal fusion
cells (Fig. 7A), and CG15252 is expressed only in DT fusion
cells (Fig. 7D). Expression of both genes was assayed in btl-
Gal4 UAS-dys embryos. CG13196 was robustly misexpressed
throughout the trachea, including all primary branches (Fig.
7B). CG15252 was misexpressed, but the misexpression was
restricted mainly to DTs and some cells in the adjacent trans-
verse connective (Fig. 7E). Clearly absent was CG15252 ex-
pression in DBs, LTs, and GBs. The esg gene, which is ex-
pressed in fusion cells but is not a Dys target gene, was not
ectopically expressed in btl-Gal4 UAS-dys embryos (not
shown). Thus, ectopic tracheal gene expression by Dys seems
specific for Dys target genes and not for all fusion cell-ex-
pressed genes. CG13196 and CG15252 expression required
Dys DNA binding, since misexpression of dys-b failed to
activate their transcription (Fig. 7C and F). Neither gene is
expressed in nontracheal sites of dys expression, such as lead-
ing-edge and anal pad cells, nor does btl-Gal4 UAS-dys central
nervous system midline cell expression result in ectopic expres-
sion of CG13196 or CG15252 in the central nervous system
midline cells. Thus, while Dys:Tgo is able to efficiently activate
transcription of fusion cell target genes throughout the tra-
chea, it is unable to activate them indiscriminately in all cell
types.
FIG. 4. Live imaging of wild-type and dys mutant tracheae. DB migration and fusion were examined by live confocal imaging of tracheal GFP
fluorescence. Shown are individual images from a wild-type btl-Gal4 UAS-actin-GFP embryo (A to E) imaged over 2 h and a dys2/dys3 btl-Gal4
UAS-actin-GFP mutant embryo (F to N) imaged over 4 h. Filopodia from tip/fusion cells (arrowheads) can be observed in both migrating wild-type
(A and B) and dys mutant (F to N) trachea. Note the accumulation of actin-GFP at sites of fusion in wild-type embryos (C to E). In the dys mutant
embryo, the fusion cells come into close range (F to N) but fail to form stable contacts.
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The isolation of dys mutants allowed detailed phenotypic
analysis using time-lapse confocal microscopy of live embryos.
Migration and the presence of filopodia during DB branching
appeared normal in dys mutant embryos. The two DB fusion
cells moved close together, and their filopodia were observed
to touch. However, unlike wild-type cells, the dys mutant fusion
cells failed to stably adhere. Thus, no fusion occurred, and
ultimately the branches retracted from one another. Addi-
tional insight into the role of dys emerged from experiments in
which dys was misexpressed throughout the trachea. Ectopic
fusion events were observed, which is consistent with the dys
mutant phenotype and indicates that dys promotes fusion cell
recognition/adhesion. In addition, dys misexpression results in
a strong reduction in both tracheal branching and formation of
MAb 2A12 luminal material at fusion sites. The reduction in
branching suggests that another possible function of dys is to
inhibit migration in preparation for fusion. The reduction in
MAb 2A12 luminal material at sites of normal and ectopic
fusion suggests that the fusion process is incomplete. This can
be explained for the ectopic fusion results by proposing that
Dys activates genes that can mediate fusion but not lumen
formation. Since the ectopic cells are not fusion cells, the
additional lumen-forming functions would not be present. In
contrast, since lumen formation was also defective at normal
fusion sites, it is possible that Dys overexpression inhibits lu-
men formation. In summary, the genetic and misexpression
experiments suggest that dys is activated late in the branching
process to inhibit migration and promote branch recognition
and adhesion. It may also play additional roles after branches
join.
Since dys encodes a transcription factor, it is expected that it
functions by regulating gene expression. Previous work had
identified several genes prominently expressed in fusion cells,
as well as additional trachea-expressed genes whose fusion cell
expression was low or absent (26, 31). In this paper, we further
showed that a number of prominent trachea-expressed genes
are also downregulated in fusion cells, indicating that this is a
common occurrence. Expression of 19 genes was assayed in dys
mutant embryos to identify Dys target genes. RNA levels of
four genes (CG13196, CG15252, mbo, and shg) were reduced.
In contrast, Trh protein levels, which normally decline in fu-
sion cells, increased in dys mutants. These results were con-
firmed by dys misexpression experiments, in which CG13196
and CG15252 were increased and Trh protein levels declined.
Despite dys expression in all tracheal fusion cells, there exist
branch-specific differences in Dys-regulated gene expression.
CG13196 is expressed in all fusion cells, and dys is required for
its expression. In contrast, shg is upregulated in DB and DT
fusion cells, but only DB upregulation requires Dys, an effect
also seen for Esg (31). CG15252 is expressed only in DT fusion
cells, and this restriction may be due to the positive or negative
action of branch-specific transcription factors, such as Spalt
major (DT specific, positively acting) (7, 15) or Kni and Knrl
(non-DT branches, negatively acting) (5, 18).
All of the dys misexpression defects (and thus probably the
mutant defects) require Dys DNA binding, since deletion of
the dys basic region, and presumably its ability to bind DNA,
abolishes the tracheal defects. Although trh RNA levels de-
FIG. 5. Misexpression of dys results in tracheal fusion, migration,
and lumen formation defects. All embryos are stage 16, and sagittal
views are shown. Embryos were stained with combinations of MAb
2A12 (red), anti-Dys (blue), and anti-GFP (green). (A) btl-Gal4 UAS-
dys embryo showing the strong misexpression of Dys protein through-
out the trachea. The DT and LT are indicated. (B) w control embryo.
Note the extensive branching (arrowheads) illustrated by MAb 2A12
staining, including DBs. (C and D) btl-Gal4 UAS-dys UAS-GFP em-
bryo. (C) MAb 2A12 staining reveals that the trachea shows a severe
reduction in secondary and tertiary branching, as well as breaks in
lumen formation at normal sites of fusion (arrowheads). Both DBs and
GBs are severely stunted (arrows in C and D show lack of DB exten-
sion; compare to panels B and G). (D) Staining for cytoplasmic GFP
shows that both the DT and LT are often joined at fusion sites, but
(C) show an absence of MAb 2A12 luminal staining. (E and F) Two
btl-Gal4 UAS-dys UAS-actin-GFP embryos. Arrowheads point to sites
of ectopic fusion. While the cytoplasmic GFP staining is continuous,
MAb 2A12 luminal staining is absent at fusion sites. The DT is indi-
cated. (G and H) btl-Gal4 UAS-dys-b embryo. The trachea has a
wild-type pattern of branching.
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FIG. 6. Regulation of gene expression in tracheal fusion cells. Each panel consists of a projection of three consecutive 1-m confocal slices.
(A to D) shg upregulation in DBs is dependent on dys function. Stage 16 shg-lacZ embryos were stained with anti--galactosidase (A1 and B2;
blue), MAb 2A12 (A1 and B1; red), and anti-Dys (not shown). The use of anti-Dys staining allows for selection of homozygous mutant embryos,
since they do not possess antibody-reactive protein. Fusion cells (arrowheads) express a higher level of -galactosidase than surrounding tracheal
cells in wild-type DB (A1 and A2). This upregulation was not observed in dys mutant DB fusion cells (B1 and B2, arrowheads). (C1 to M2) Embryos
were hybridized to gene-specific probes and a dys RNA probe and immunostained with anti-Dys. dys RNA hybridization revealed fusion cells, and
anti-Dys allowed identification of dys mutant embryos. (C1 and C2) CG13196 fusion cell expression is dependent on dys. Stage 15 wild-type DT
fusion cells express CG13196 (C1), but dys mutants (C2) do not. (D1 and D2) mbo expression is regulated by dys. Fusion-4 embryos, which contain
an mbo-lacZ enhancer trap gene, were immunostained with anti--galactosidase. Stage 15 wild-type DT (D1) fusion cells (arrowheads) show high
levels of lacZ expression, whereas -galactosidase expression is absent in dys mutant DT (D2). (E1 and E2) CG15252 fusion cell expression is
dependent on dys. Stage 15 wild-type DT fusion cells (E1) express CG15252, but dys mutants (E2) do not. (F) Misexpression of CG13196 in
btl-Gal4 UAS-CG13196 embryos results in ectopic tracheal branch fusion (arrowhead). (G to K) Stage 15 embryos were hybridized to apt (G), kni
(H), trh (I), vvl (J), and btl (K) probes as well as to a dys probe to mark fusion cells (not shown). RNA levels of all five genes are downregulated
in fusion cells but are not regulated by dys (not shown). (L1 to M2) dys downregulates Trh protein levels. Trh protein levels are reduced in wild-type
(L1) DT fusion cells (arrowheads) and (M1) DB fusion cells (arrowheads). In dys mutant embryos, Trh proteins levels increased to levels
comparable to those in other tracheal cells in both DTs (L2) and DBs (M2). (N1 to N4) Embryos stained with ant-Trh (green). (N1) w control
embryo. Trh is localized to nuclei at uniform levels throughout the trachea. Cells of the spiracular branch (arrowheads) show the same levels of
Trh as other tracheal cells. (N2 and N3) btl-Gal4 UAS-dys embryo. (N2) Embryo stained with MAb 2A12 (red), anti-Dys (blue), and anti-Trh
(green). btl-Gal4 UAS-dys is expressed at high levels in all tracheal cells except the spiracular branch cells (green; arrowheads). (N3) Trh levels are
reduced in dys-positive cells (arrow) compared to spiracular branch cells (arrowheads). (N4) btl-Gal4 UAS-dys-b embryo. Trh levels are uniform
throughout the trachea, as indicated by comparable Trh levels in dys-positive cells (arrow) compared to spiracular branch cells (arrowheads).
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cline in fusion cells along with protein levels, the RNA reduc-
tion is not dys dependent. Thus, dys likely regulates transcrip-
tion of a gene that regulates Trh protein levels. Similarly, the
requirement of Dys DNA binding to regulate Trh protein
levels does not support a model (12) in which Trh levels are
reduced as a consequence of Dys competing for their common
dimerization partner, Tgo, since this is unlikely to require
DNA binding.
The recognition/adhesive properties promoted by dys may
be mediated by two Dys target genes, shg and CG13196. Shg is
a well-studied adhesion protein, and CG13196 encodes a ZP
transmembrane protein, although its function and subcellular
localization are unknown. Misexpression of CG13196 results in
ectopic fusion events consistent with it playing a role in cell
adhesion. Thus, one key role of dys may be to promote tracheal
fusion by controlling expression of two or more cell adhesion
protein genes. They could work together in the same cellular
process or in different aspects of tracheal fusion, lumen for-
mation, or function. The identification of mbo as a transcrip-
tional target of Dys is intriguing, since mbo mutants have a
tracheal fusion defect (35) and it attenuates protein nuclear
export (25). Although the fusion cell protein cargo regulated
by mbo is unknown, it presumably includes proteins that are
localized to nuclei in fusion cells.
The two major transcription factors studied to date that
control fusion cell transcription and development are esg and
dys. esg precedes dys during fusion cell development and con-
trols expression of dys in DBs and GBs but not DTs (12) (the
case for LTs is unknown, since fusion cells die in esg mutants
[27]). dys itself does not affect esg expression (12). The tracheal
fusion phenotypes of both genes are similar. The DT is the one
branch that still fuses in both esg and dys mutants, although
both show constrictions at the sites of DT fusion (27, 31).
Previous work on esg revealed that, genetically, it is required
for both activation of fusion cell gene expression and repres-
sion of terminal cell gene expression in fusion cells (27, 31). In
this study, we found that dys constitutes a transcriptional path-
way that carries out a subset of esg functions, focused on
upregulating expression of genes involved in cell adhesion and
protein localization, although future work may uncover addi-
tional target genes. Since a large number of genes are either
activated or downregulated in tracheal fusion cells (L. Jiang,
unpublished data), it will be important to continue genetic and
molecular studies to determine which genes are targets of Esg
and Dys and whether their control is direct or indirect.
One model of Drosophila dys function is that dys acts as a
developmental timer near the end of tracheal branching to
inhibit migration and promote cell adhesion and fusion. The
adhesion component works, in part, through activation of shg
and (possibly) CG13196. The inhibition of migration has only
FIG. 7. Misexpression of dys in trachea results in ectopic expression of dys target genes. All panels show sagittal views of stage 16 embryos;
anterior is to the left. Positions of DTs (arrowheads) and LTs (arrows) are indicated. (A to C) w (A), btl-Gal4 UAS-dys (B), and btl-Gal4
UAS-dys-b (C) embryos were hybridized to a CG13196 probe (red). Embryos were also stained with anti-Dys to monitor misexpression (not
shown). (A) In w control embryos, CG13196 is expressed in fusion cells of DTs and LTs. (B) CG13196 expression is found throughout the trachea
when dys is ectopically expressed. (C) Only wild-type expression of CG13196 in DTs and LTs is observed when dys-b is misexpressed. (D to F)
w (D), btl-Gal4 UAS-dys (E), and btl-Gal4 UAS-dys-b (F) embryos were hybridized to a CG15252 probe (red). (D) CG15252 is expressed only
in DT fusion cells in w control embryos. (E) CG15252 expression is ectopically expressed when dys is misexpressed in all tracheal cells, but it is
restricted to DT and some nearby tracheal cells. It is completely absent from LTs and GBs. (F) CG15252 expression is restricted to DT fusion cells
and is not ectopically expressed in btl-Gal4 UAS-dys-b embryos.
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been postulated from misexpression experiments and needs to
be confirmed by alternative approaches. It is also important to
note that the switch from migration to fusion can also include
changes in gene expression that are independent of dys. For
example, it is shown here that RNA levels of btl, a gene re-
quired for tracheal migration, are downregulated in fusion
cells in a dys-independent mode. dys is expressed in a variety of
Drosophila embryonic cell types, including leading edge, brain,
gut, and anal pad (12), and the mammalian ortholog is prom-
inently expressed in the brain (17, 21). However, the function
of dys in these cell types is unknown, although a potential
connection between tracheal fusion cells and both migrating
neuronal axon growth cones and leading-edge cells is worth
investigating. The role of dys in controlling fusion cell behavior
suggests that it is worthwhile to look in tissues that undergo
branching morphogenesis, such as the vertebrate lung and vas-
cular system, for regulatory proteins expressed in tip/fusion
cells that control the migration, recognition, and fusion prop-
erties of their branches.
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